Covid19 Infection study: Covid-19 vaccine vs Influenza vaccine
Official title Covid-19 and Influenza Oral Vaccine Study
ClinicalTrials.gov ID: NCT06355232
What this study is testing
What is SpikoGen® vaccine?
This is an investigational protein-based vaccine being studied to see if it can help protect against COVID-19 when given under the tongue. It is designed to use a spike protein and an adjuvant to help your immune system recognize the virus.
Also referred to as SARS-CoV-2 vaccine.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study checks how well protein-based vaccines for COVID-19 or the flu work when given under the tongue. It also compares these to a standard flu vaccine given the same way.
- Who it's for
- The study is looking for healthy adults who have not recently had a severe reaction to vaccines.
- What's involved
- Participants will receive both a COVID-19 vaccine and a flu vaccine under the tongue. They will also get a standard flu vaccine under the tongue for comparison.
- Time commitment
- The study lasts about 4 months and requires visits to receive the different vaccines.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Able to provide written informed consent
- Males or females 18 years of age or older
- Understand and are likely to comply with planned study procedures and be available for all study visits.
- Do not plan to have a non-study COVID-19 or influenza vaccine within the next 6 months.
You likely can't join if
- Allergy to COVID-19 or seasonal influenza vaccine or one of its components e.g. polysorbate 80.
- Have received a COVID-19 or influenza vaccine or an experimental agent within 30 days prior to the study vaccination or expect to receive another...
- Any serious medical, social or mental condition which, in the opinion of the investigator, would be detrimental to the people or the study.
The study team makes the final eligibility decision.
Where it is enrolling
- Adelaide, South Australia, Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Adelaide, South Australia, Australia. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.